Resmed INC (RMD) Holder Mason Street Advisors LLC Has Lowered Holding by $3.76 Million

ResMed Inc. (NYSE:RMD) LogoInvestors sentiment increased to 1.36 in Q3 2018. Its up 0.07, from 1.29 in 2018Q2. It increased, as 17 investors sold RMD shares while 131 reduced holdings. 69 funds opened positions while 132 raised stakes. 89.08 million shares or 0.07% more from 89.02 million shares in 2018Q2 were reported. Moreover, Private Trust Na has 0.04% invested in ResMed Inc. (NYSE:RMD) for 1,874 shares. Gemmer Asset Management Limited Liability Corporation, a California-based fund reported 324 shares. Kentucky Retirement Ins Fund stated it has 0.07% in ResMed Inc. (NYSE:RMD). Merian (Uk) Ltd has 0.01% invested in ResMed Inc. (NYSE:RMD) for 13,031 shares. Moreover, Azimuth Cap Mgmt Limited Liability Co has 0.91% invested in ResMed Inc. (NYSE:RMD). Rhumbline Advisers holds 0.08% of its portfolio in ResMed Inc. (NYSE:RMD) for 348,896 shares. Retirement Of Alabama, Alabama-based fund reported 65,824 shares. Sumitomo Mitsui Asset Ltd holds 31,892 shares or 0.06% of its portfolio. Cleararc Cap holds 0.06% or 3,706 shares in its portfolio. Farmers & Merchants Inc owns 48 shares or 0% of their US portfolio. 51,218 are held by State Of Tennessee Treasury Department. Provise Gru Ltd Co reported 6,014 shares or 0.09% of all its holdings. Invsts stated it has 7.02M shares. Intrust Retail Bank Na owns 8,630 shares. Tudor Inv Corp Et Al reported 20,617 shares.

Since July 16, 2018, it had 0 insider purchases, and 23 sales for $6.26 million activity. 2,810 ResMed Inc. (NYSE:RMD) shares with value of $320,200 were sold by PENDARVIS DAVID. Sandercock Brett had sold 2,000 shares worth $225,120. 1,800 ResMed Inc. (NYSE:RMD) shares with value of $200,808 were sold by McHale Richard. On Friday, November 16 Farrell Michael J. sold $344,817 worth of ResMed Inc. (NYSE:RMD) or 3,300 shares. Douglas Robert Andrew had sold 4,291 shares worth $435,279 on Thursday, November 15.

Mason Street Advisors Llc decreased its stake in Resmed Inc (RMD) by 71.5% based on its latest 2018Q3 regulatory filing with the SEC. Mason Street Advisors Llc sold 49,537 shares as the company’s stock rose 0.79% while stock markets declined. The institutional investor held 19,741 shares of the medical and dental instruments company at the end of 2018Q3, valued at $1.52M, down from 69,278 at the end of the previous reported quarter. Mason Street Advisors Llc who had been investing in Resmed Inc for a number of months, seems to be less bullish one the $16.27 billion market cap company. The stock decreased 0.56% or $0.64 during the last trading session, reaching $114.17. About 139,559 shares traded. ResMed Inc. (NYSE:RMD) has risen 31.63% since January 14, 2018 and is uptrending. It has outperformed by 31.63% the S&P500.

Mason Street Advisors Llc, which manages about $4.08B US Long portfolio, upped its stake in Ishares Tr (IWR) by 37,850 shares to 60,200 shares, valued at $11.88 million in 2018Q3, according to the filing.

Analysts await ResMed Inc. (NYSE:RMD) to report earnings on January, 24 after the close. They expect $0.93 earnings per share, down 7.00 % or $0.07 from last year’s $1 per share. RMD’s profit will be $132.52M for 30.69 P/E if the $0.93 EPS becomes a reality. After $0.81 actual earnings per share reported by ResMed Inc. for the previous quarter, Wall Street now forecasts 14.81 % EPS growth.

Another recent and important ResMed Inc. (NYSE:RMD) news was published by which published an article titled: “ResMed to Report Second Quarter Fiscal 2019 Earnings on January 24, 2019 – Business Wire” on January 03, 2019.

ResMed Inc. (NYSE:RMD) Institutional Positions Chart

(adsbygoogle = window.adsbygoogle || []).push({});

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.